Dermata Therapeutics Inc. (DRMAW)

AI Score

Unlock

0.03

0.01 (50.00%)

At close: Apr 22, 2025, 3:46 PM

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-3.2M	-3.23M	-2.88M	-3.2M	-2.22M	-1.81M	-1.73M	-2.28M	-1.71M	-2.45M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.26M	-491.43K	-540.06K	-792.79K	-1.35M
Interest Income	49.35K	52.5K	54.64K	69.3K	85.86K	92.77K	31.05K	37.54K	42.09K	21.49K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3.15M	-3.17M	-2.83M	-3.13M	-2.13M	-1.72M	-1.7M	-2.24M	-1.67M	-2.42M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.3M	-396.31K	-597.39K	-821.65K	-1.42M
Net Income	-3.15M	-3.17M	-2.83M	-3.13M	-2.13M	-1.72M	-1.7M	-2.24M	-1.59M	-2.38M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.3M	-396.31K	-597.39K	-821.65K	-1.42M
Selling & General & Admin	1.01M	824.29K	874.64K	1.6M	1.08M	909K	893.48K	1.09M	822.33K	892.78K	1.12M	1.19M	1.44M	912.49K	462.77K	1.58M	377.13K	419.6K	380.84K	387.47K
Research & Development	2.19M	2.4M	2.01M	1.6M	1.14M	902.98K	838.93K	1.19M	889.36K	1.55M	1.61M	1.6M	1.11M	799.78K	867.2K	680.59K	114.3K	120.47K	411.95K	961.1K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.2M	3.23M	2.88M	3.2M	2.22M	1.81M	1.73M	2.28M	1.71M	2.45M	2.73M	2.79M	2.55M	1.71M	1.33M	2.26M	491.43K	540.06K	792.79K	1.35M
Interest Expense	n/a	n/a	n/a	n/a	37.54K	n/a	n/a	n/a	42.09K	21.49K	n/a	n/a	45.57M	651.00	1.82K	43.13K	38.48K	57.33K	28.86K	72.6K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	3.2M	3.23M	2.88M	3.2M	2.22M	1.81M	1.73M	2.28M	1.71M	2.45M	2.73M	2.79M	2.55M	1.71M	1.33M	2.26M	491.43K	540.06K	792.79K	1.35M
Income Tax Expense	n/a	n/a	n/a	-3.2M	-2.22K	-1.81K	-1.73K	n/a	-84.17K	-42.97K	-2.73M	-2.79M	-45.57M	-81	-81	-81	78.46K	-52.75K	-51.12K	n/a
Shares Outstanding (Basic)	1.55M	1.55M	676.57K	444.06K	3.93M	3.19M	2.7M	65.72K	770.12K	767.27K	699.68K	520.54K	8.35M	311.27K	469.74K	520.54K	8.33M	520.54K	520.54K	520.54K
Shares Outstanding (Diluted)	1.55M	1.55M	676.57K	444.06K	3.93M	3.19M	2.7M	65.72K	770.12K	767.27K	699.68K	522.03K	8.35M	311.27K	469.74K	520.54K	8.33M	520.54K	520.54K	520.54K
EPS (Basic)	-2.04	-2.04	-4.18	-7.06	-0.54	-0.54	-0.63	-34.08	-2.06	-3.1	-3.9	-5.35	-0.31	-5.5	-2.84	-4.43	-0.05	-1.15	-1.58	-2.73
EPS (Diluted)	-2.04	-2.04	-4.18	-7.06	-0.54	-0.54	-0.63	-34.08	-2.06	-3.1	-3.9	-5.34	-0.31	-5.5	-2.84	-4.43	-0.05	-1.15	-1.58	-2.73
EBITDA	-3.2M	-3.23M	-2.88M	n/a	-2.13M	-1.81M	-1.73M	-2.28M	n/a	-2.45M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.26M	-357.83K	-540.06K	-792.79K	-1.35M
EBIT	-3.2M	-3.23M	-2.88M	-3.2M	-2.22M	-1.81M	-1.73M	-2.28M	-1.71M	-2.45M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.26M	-357.83K	-540.06K	-792.79K	-1.35M
Depreciation & Amortization	n/a	n/a	2.00	3.2M	2.22M	1.81M	1.73M	n/a	1.71M	2.45M	2.73M	2.79M	81.00	81.00	81.00	81.00	133.59K	52.75K	51.12K	322.00